Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Dec;13(4):471-83.
doi: 10.1007/s10911-008-9104-6. Epub 2008 Nov 21.

IGF-1 receptor inhibitors in clinical trials--early lessons

S John Weroha  1 , Paul Haluska
Affiliations
Review

IGF-1 receptor inhibitors in clinical trials--early lessons

S John Weroha et al. J Mammary Gland Biol Neoplasia. 2008 Dec.

Abstract

The insulin-like growth factor pathway plays a major role in cancer cell proliferation, survival and resistance to anti-cancer therapies in many human malignancies, including breast cancer. As a key signaling component of IGF system, the IGF-1 receptor is the target of several investigational agents in clinical and pre-clinical development. This review will focus on the rationale for targeting the IGF-1 receptor and other components of the IGF-1 system. In addition, we will examine the role of IGF-1 signaling in resistance to clinically important breast cancer therapies, including cytotoxic chemotherapy, hormonal therapy and erbB targeted agents. We will also review the completed and ongoing clinical investigations with IGF-1 receptors inhibitors to date and the utility of these early data in designing future breast cancer studies with IGF-1 signaling inhibition strategies.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Model of IGF system inhibition strategies. a Monoclonal antibody strategy; b tyrosine kinase inhibitor strategy; c ligand sequestration strategy.
See this image and copyright information in PMC

References

    1. Sell C, Rubini M, Rubin R, Liu JP, Efstratiadis A, Baserga R. Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor. Proc Natl Acad Sci USA. 1993;90(23):11217–21. doi: 10.1073/pnas.90.23.11217. - DOI - PMC - PubMed
    1. Carboni JM, Lee AV, Hadsell DL, Rowley BR, Lee FY, Bol DK, et al. Tumor development by transgenic expression of a constitutively active insulin-like growth factor I receptor. Cancer Res. 2005;65(9):3781–7. doi: 10.1158/0008-5472.CAN-04-4602. - DOI - PubMed
    1. Lopez T, Hanahan D. Elevated levels of IGF-1 receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis. Cancer Cell. 2002;1(4):339–53. doi: 10.1016/S1535-6108(02)00055-7. - DOI - PubMed
    1. Yakar S, Leroith D, Brodt P. The role of the growth hormone/insulin-like growth factor axis in tumor growth and progression: lessons from animal models. Cytokine Growth Factor Rev. 2005;16(4–5):407–20. doi: 10.1016/j.cytogfr.2005.01.010. - DOI - PubMed
    1. Hartog H, Wesseling J, Boezen HM, van der Graaf WT. The insulin-like growth factor 1 receptor in cancer: old focus, new future. Eur J Cancer. 2007;43(13):1895–904. doi: 10.1016/j. ejca.2007.05.021. - DOI - PubMed

Publication types

MeSH terms